Friday, July 24, 2020
Industry wants an overhaul of CMS' plan for Medicaid value-based drugs
Industry wants an overhaul of CMS' plan for Medicaid value-based drugs: Industry stakeholders say CMS is rushing its plan to help state Medicaid programs, health plans and drugmakers create value-based arrangements for prescription drugs. The proposal also could create an administrative nightmare.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment